UPDATE : Tuesday, October 15, 2019
상단여백
Galderma Korea workers feel insecure after separation from Nestle
Galderma has debuted as a rebranded dermatology company after separation fr...
by Kim Yun-mi  |  2019-10-07 14:38
라인
Albis most prescribed ranitidine drug with carcinogen risk
Physicians have prescribed Albis Tab. the most among ranitidine-containing ...
by Kwak Sung-sun  |  2019-10-07 11:23
라인
Qurient sets up joint firm with Nobel chemistry prize winner
Qurient has established a joint venture with Professors Robert Huber, a res...
by Lee Han-soo  |  2019-10-04 17:45
라인
Lilly's Verzenio extends life for women with advanced breast cancer
Lilly said a combination therapy of Verzenio and fulvestrant significantly ...
by Lee Han-soo  |  2019-10-04 16:15
라인
Eisai’s hepatocellular carcinoma treatment Lenvima to get insurance benefit
The government said it would grant insurance benefit to Eisai’s Lenvima (in...
by Lee Han-soo  |  2019-10-02 16:10
라인
CDK4/6 inhibitor+fulvestrant combo nears getting benefit
The combination therapy of cyclin-dependent kinase 4/6 (CDK 4/6) inhibitor ...
by Kim Yun-mi  |  2019-10-02 16:03
라인
Daewoong's EU partner wins sales approval for BTX
Daewoong Pharmaceutical said that Evolus, its U.S. and EU partner, has rece...
by Lee Han-soo  |  2019-10-02 14:51
라인
Daewoong's reaffirms drug-marketing power with Daiichi Sankyo's NOAC treatment
Daewoong proved its sales power once again as it solidified its top positio...
by Lee Han-soo  |  2019-10-01 16:43
라인
Drugmakers’ illegal rebates down, support for doctors up
Pharmaceutical companies’ offering of illicit rebates to physicians have de...
by Kwak Sung-sun  |  2019-10-01 13:49
라인
Crystal Genomics confirms efficacy of epigenetics-based pulmonary fibrosis treatment
Crystal Genomics said it has presented the results of the preclinical study...
by Lee Han-soo  |  2019-10-01 11:21
라인
‘Merck Korea unilaterally lays off employees’
Merck Biopharma Korea has been embroiled in a labor dispute.Merck Korea bra...
by Kim Yun-mi  |  2019-10-01 11:09
라인
Allergan to compensate breast implant recipients for damage
Allergan agreed to provide full compensation for the medical expenses of pa...
by Lee Hye-seon  |  2019-09-30 15:33
라인
Ranitidine recall taking heavy toll on pharmaceuticals
Pharmaceutical companies are expected to suffer massive losses due to the r...
by Jeong Sae-im  |  2019-09-30 15:16
라인
Sale of Novartis’ conjunctivitis drug Pataday banned for 3 months
The Ministry of Food and Drug Safety has suspended the sale of Novartis Kor...
by Lee Hye-seon  |  2019-09-30 11:25
라인
Investor trust in bio-industrialists sank due to latter’s unethical acts
The biotech industry is losing trust from investors as some executives at t...
by Lee Han-soo  |  2019-09-27 15:11
라인
Genexine sets up joint firm in Thailand
Genexine said that it has established KinGen Biotech in Thailand, a joint v...
by Lee Han-soo  |  2019-09-26 17:00
라인
[Analysis] Successive failures throw Korean bioindustry's drug-developing ability into question
The recent failures by Korean biotech companies to reach meaningful results...
by Lee Han-soo  |  2019-09-26 15:39
라인
Pfizer’s leukemia therapy Besponsa to get insurance benefit
The government said it would grant insurance benefit to Pfizer’s leukemia t...
by Kim Yun-mi  |  2019-09-26 11:26
라인
'Xtandi emerges as convenient treatment option for prostate cancer patients'
Astellas Korea is strengthening its position in the local prostate cancer m...
by Lee Han-soo  |  2019-09-25 17:39
라인
Huons, Lipac Oncology to co-develop bladder cancer treatment
Huons said that it has signed an exclusive licensing agreement for developi...
by Lee Han-soo  |  2019-09-25 11:18
여백
여백
여백
Back to Top